KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 170 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $12,613,000 | +10.5% | 1,961,588 | 0.0% | 0.02% | +21.1% |
| Q3 2021 | $11,416,000 | -58.5% | 1,961,588 | -26.3% | 0.02% | -53.7% |
| Q2 2021 | $27,484,000 | -2.1% | 2,663,177 | -0.2% | 0.04% | -2.4% |
| Q1 2021 | $28,070,000 | -32.0% | 2,668,199 | +0.1% | 0.04% | -37.3% |
| Q4 2020 | $41,276,000 | +30.6% | 2,666,416 | +23.2% | 0.07% | +13.6% |
| Q3 2020 | $31,608,000 | -19.2% | 2,164,900 | +4.8% | 0.06% | -40.4% |
| Q2 2020 | $39,110,000 | -6.0% | 2,064,900 | -4.6% | 0.10% | -44.4% |
| Q1 2020 | $41,587,000 | +1635.7% | 2,164,900 | +1631.9% | 0.18% | +1877.8% |
| Q4 2019 | $2,396,000 | – | 125,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,767,078 | $80,993,000 | 5.22% |
| Palo Alto Investors LP | 4,663,324 | $79,230,000 | 3.17% |
| DOHENY ASSET MANAGEMENT /CA | 282,945 | $4,807,000 | 2.61% |
| Private Capital Advisors, Inc. | 416,900 | $7,083,000 | 2.22% |
| Sandia Holdings, LLC | 119,739 | $2,034,000 | 0.91% |
| Virtus ETF Advisers LLC | 44,986 | $764,000 | 0.68% |
| Birchview Capital, LP | 50,000 | $850,000 | 0.58% |
| Schonfeld Strategic Advisors LLC | 415,600 | $7,061,000 | 0.38% |
| EMERALD ADVISERS, LLC | 561,317 | $9,537,000 | 0.36% |
| Kazazian Asset Management, LLC | 20,672 | $351,000 | 0.32% |